Chronic kidney disease (CKD) affects over 3.5 million people in the UK and is expected to rise to over 4 million by 2030. One of the challenges with CKD is that its symptoms often go unnoticed until the disease reaches an advanced stage.
Without early detection and proactive change, many individuals in West Yorkshire and beyond may face serious complications, including the onset of long-term health conditions. Early testing is essential to manage CKD effectively, especially for individuals at a higher risk including people with high blood pressure or hypertension.
Routine urine albumin-to-creatinine ratio (uACR) testing for patients with hypertension can help detect kidney damage early. Detecting CKD early can slow disease progression, reduce the risk of cardiovascular complications and help avoid the need for dialysis or kidney transplants.